World's Best Scientists 2026 revealed!

D-Index & Metrics

Psychology

D-Index
67
Citations
20315
World Ranking
2565
National Ranking
284

Marta Di Forti publication distribution in Psychology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Psychology in 2026. The highlighted bar marks where Marta Di Forti sits on this spectrum.

31–40 publications: 6 scientists 41–50 publications: 52 scientists 51–60 publications: 138 scientists 61–70 publications: 299 scientists 71–80 publications: 461 scientists 81–90 publications: 605 scientists 91–100 publications: 713 scientists 101–110 publications: 736 scientists 111–120 publications: 686 scientists 121–130 publications: 670 scientists 131–140 publications: 644 scientists 141–150 publications: 597 scientists 151–160 publications: 576 scientists 161–170 publications: 477 scientists 171–180 publications: 450 scientists 181–190 publications: 397 scientists 191–200 publications: 343 scientists 201–210 publications: 328 scientists 211–220 publications: 313 scientists 221–230 publications: 283 scientists 231–240 publications: 226 scientists 241–250 publications: 196 scientists 251–260 publications: 201 scientists 261–270 publications: 171 scientists 271–280 publications: 151 scientists 281–290 publications: 139 scientists 291–300 publications: 113 scientists 301–310 publications: 102 scientists 311–320 publications: 100 scientists 321–330 publications: 76 scientists 331–340 publications: 92 scientists 341–350 publications: 85 scientists 351–360 publications: 69 scientists 361–370 publications: 71 scientists 371–380 publications: 63 scientists 381–390 publications: 58 scientists 391–400 publications: 57 scientists 401–410 publications: 43 scientists 411–420 publications: 33 scientists 421–430 publications: 50 scientists 431–440 publications: 41 scientists 441–450 publications: 32 scientists 451–460 publications: 27 scientists 461–470 publications: 28 scientists 471–480 publications: 25 scientists 481–490 publications: 28 scientists 491–500 publications: 20 scientists 501–510 publications: 23 scientists 511–520 publications: 26 scientists 521–530 publications: 17 scientists 531–540 publications: 21 scientists 541–550 publications: 14 scientists 551–560 publications: 16 scientists 561–570 publications: 10 scientists 571–580 publications: 22 scientists 581–590 publications: 9 scientists 591–600 publications: 14 scientists 601–610 publications: 9 scientists 611–620 publications: 11 scientists 621–630 publications: 4 scientists 631–640 publications: 7 scientists 641–650 publications: 5 scientists 651–660 publications: 10 scientists 661–670 publications: 8 scientists 671–680 publications: 8 scientists 681–690 publications: 4 scientists 691–700 publications: 3 scientists 701–704 publications: 4 scientists 705+ publications: 100 scientists
31 publications 705+

This scientist: 422 publications — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 705 publications or more.

Marta Di Forti D-index placement in Psychology in 2026

The chart shows the D-index (discipline H-index) distribution of Psychology scientists ranked by Research.com in 2026. The highlighted bar marks where Marta Di Forti sits on this spectrum.

30–31 D-Index: 398 scientists 32–33 D-Index: 702 scientists 34–35 D-Index: 671 scientists 36–37 D-Index: 659 scientists 38–39 D-Index: 641 scientists 40–41 D-Index: 671 scientists 42–43 D-Index: 617 scientists 44–45 D-Index: 558 scientists 46–47 D-Index: 495 scientists 48–49 D-Index: 487 scientists 50–51 D-Index: 445 scientists 52–53 D-Index: 390 scientists 54–55 D-Index: 408 scientists 56–57 D-Index: 345 scientists 58–59 D-Index: 325 scientists 60–61 D-Index: 321 scientists 62–63 D-Index: 248 scientists 64–65 D-Index: 290 scientists 66–67 D-Index: 218 scientists 68–69 D-Index: 219 scientists 70–71 D-Index: 215 scientists 72–73 D-Index: 183 scientists 74–75 D-Index: 169 scientists 76–77 D-Index: 132 scientists 78–79 D-Index: 137 scientists 80–81 D-Index: 120 scientists 82–83 D-Index: 112 scientists 84–85 D-Index: 86 scientists 86–87 D-Index: 101 scientists 88–89 D-Index: 83 scientists 90–91 D-Index: 77 scientists 92–93 D-Index: 70 scientists 94–95 D-Index: 78 scientists 96–97 D-Index: 58 scientists 98–99 D-Index: 53 scientists 100–101 D-Index: 57 scientists 102–103 D-Index: 48 scientists 104–105 D-Index: 53 scientists 106–107 D-Index: 46 scientists 108–109 D-Index: 24 scientists 110–111 D-Index: 35 scientists 112–113 D-Index: 27 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 31 scientists 118–119 D-Index: 22 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 24 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 11 scientists 128–129 D-Index: 19 scientists 130–131 D-Index: 10 scientists 132–133 D-Index: 16 scientists 134–135 D-Index: 10 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 5 scientists 142–143 D-Index: 12 scientists 144+ D-Index: 98 scientists
30 D-Index 144+

This scientist: 67 D-Index — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 144 D-Index or more.

Overview

Marta Di Forti is a researcher affiliated with King's College London in the United Kingdom. Their academic work spans the fields of Medicine and Psychology, with a particular focus on Psychiatry and Mental Health, Pharmacology, Clinical Psychology, Genetics, and Experimental and Cognitive Psychology. The primary topics addressed in their research include schizophrenia research and treatment, cannabis and cannabinoid research, bipolar disorder and treatment, genetic associations and epidemiology, mental health treatment and access, child and adolescent psychosocial and emotional development, as well as tryptophan and brain disorders.

Their publication record includes contributions to several prominent scientific journals. Frequent publication venues for their work include Psychological Medicine, Schizophrenia Bulletin, European Neuropsychopharmacology, Schizophrenia Research, and bioRxiv (Cold Spring Harbor Laboratory).

Among recent notable papers associated with Marta Di Forti's research collaborations are:

  • "Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta-analysis" (2020, Addiction)
  • "Genetic variants associated with longitudinal changes in brain structure across the lifespan" (2022, Nature Neuroscience)
  • "Multivariate genome-wide association meta-analysis of over 1 million subjects identifies loci underlying multiple substance use disorders" (2023, Nature Mental Health)
  • "DNA methylation meta-analysis reveals cellular alterations in psychosis and markers of treatment-resistant schizophrenia" (2021, eLife)
  • "A systematic review on mediators between adversity and psychosis: potential targets for treatment" (2020, Psychological Medicine)

Marta Di Forti has collaborated frequently with a group of researchers including Robin Murray, Diego Quattrone, Craig Morgan, Charlotte Gayer-Anderson, and Caterina La Cascia, contributing to multiple joint publications.

Their scientific investigations focus heavily on understanding mental health disorders, genetic influences, and the pharmacological and psychosocial aspects of psychiatric conditions. The interdisciplinary nature of their studies integrates genetics, clinical assessments, and epidemiological methods to explore complex mechanisms underlying mental illnesses such as schizophrenia and bipolar disorder, often with an emphasis on the influence of cannabis use.

Best Publications

  • Large recurrent microdeletions associated with schizophrenia

    Hreinn Stefansson;Dan Rujescu;Sven Cichon;Olli P. H. Pietilainen

  • Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis

    Arianna Marconi;Marta Di Forti;Cathryn M Lewis;Robin M Murray

  • The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study

    Marta Di Forti;Marta Di Forti;Marta Di Forti;Diego Quattrone;Diego Quattrone;Diego Quattrone;Tom P. Freeman;Giada Tripoli

  • Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes

    Douglas M. Ruderfer;Stephan Ripke;Stephan Ripke;Stephan Ripke;Andrew McQuillin;James Boocock

  • Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study.

    Marta Di Forti;Arianna Marconi;Elena Carra;Sara Fraietta

  • High-potency cannabis and the risk of psychosis

    Marta Di Forti;Craig Morgan;Paola Dazzan;Carmine Pariante

  • Daily Use, Especially of High-Potency Cannabis, Drives the Earlier Onset of Psychosis in Cannabis Users.

    Marta Di Forti;Hannah M Sallis;Fabio Allegri;Antonella Trotta

  • Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders

    Tarjinder Singh;Mitja I Kurki;David Curtis;Shaun M Purcell

  • Cannabis, the mind and society: the hash realities

    Robin M. Murray;Paul D. Morrison;Cécile Henquet;Marta Di Forti

  • Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume.

    Valeria Mondelli;Annamaria Cattaneo;Martino Belvederi Murri;Marta Di Forti

  • Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: The role of stress and of antipsychotic treatment

    Valeria Mondelli;Paola Dazzan;Nilay Hepgul;Marta Di Forti

  • Gene-Environment Interplay Between Cannabis and Psychosis

    Cécile Henquet;Marta Di Forti;Paul Morrison;Rebecca Kuepper

  • Identifying Gene-Environment Interactions in Schizophrenia: Contemporary Challenges for Integrated, Large-scale Investigations

    Jim van Os;Jim van Os;Bart P. Rutten;Inez Myin-Germeys;Philippe Delespaul

  • Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis.

    Robin M. Murray;Harriet Quigley;Diego Quattrone;Amir Englund

  • Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses

    J. Lally;O. Ajnakina;M. Di Forti;A. Trotta

  • Confirmation that the AKT1 (rs2494732) Genotype Influences the Risk of Psychosis in Cannabis Users

    Marta Di Forti;Conrad Iyegbe;Hannah Sallis;Anna Kolliakou

  • Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis

    Valeria Mondelli;Valeria Mondelli;Simone Ciufolini;Simone Ciufolini;Martino Belvederi Murri;Stefania Bonaccorso

  • Drug-Induced Psychosis: How to Avoid Star Gazing in Schizophrenia Research by Looking at More Obvious Sources of Light

    Alessandra Paparelli;Marta Di Forti;Paul D. Morrison;Robin M. Murray

  • Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta-analysis.

    Tom P. Freeman;Tom P. Freeman;Sam Craft;Sam Craft;Jack Wilson;Stephan Stylianou

  • Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics?

    Robin MacGregor Murray;Diego Quattrone;Sridhar Natesan;Johannas Van Os

  • Cannabis use in young people: the risk for schizophrenia.

    Paola Casadio;Cathy Fernandes;Robin M. Murray;Marta Di Forti

Frequent Co-Authors

Robin M. Murray
Robin M. Murray King's College London
Craig Morgan
Craig Morgan King's College London
Paola Dazzan
Paola Dazzan King's College London
Valeria Mondelli
Valeria Mondelli King's College London
Carmine M. Pariante
Carmine M. Pariante King's College London
Jim van Os
Jim van Os University Medical Center Utrecht
Anthony S. David
Anthony S. David University College London
Helen L. Fisher
Helen L. Fisher King's College London
Cathryn M. Lewis
Cathryn M. Lewis King's College London
Pak C. Sham
Pak C. Sham University of Hong Kong

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Psychology opens the door to diverse online programs and rewarding career paths in mental health. Many students choose online degrees for their flexibility and wide range of specializations, including counseling, clinical psychology, and therapy.

To practice as a licensed therapist in the U.S., graduates must meet state-specific requirements, complete supervised clinical hours, and often pass a national examination. The pathway can vary significantly by location—prospective therapists in Arizona can review the Mesa licensed therapist education requirements for local details. In Miami, students should familiarize themselves with the steps for becoming a licensed therapist in Miami.

If you plan to work in the Midwest, the Milwaukee licensed therapist requirements and Minneapolis licensed therapist requirements offer useful state-by-state guidance. No matter your location, completing a recognized psychology program lays a solid foundation for multiple career pathways—including counseling, academia, research, and specialized therapeutic roles.

Best Scientists Citing Marta Di Forti

Trending Scientists

Recently Published Articles